{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-22-023298","form_type":"8-K","ticker":"AURX","cik":"0001091596","company_name":"Nuo Therapeutics, Inc.","filed_at":"2022-09-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:54.955787+00:00","generated_at":"2026-06-23T06:16:06.251297+00:00","sec_items":["5.08","8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Nuo Therapeutics sets 2022 Annual Meeting for Dec 2; record date Sept 30","bullets":["Annual Meeting will be held at 8285 El Rio, Suite 190, Houston, Texas on December 2, 2022.","Stockholders of record as of September 30, 2022 are entitled to vote.","Deadline for shareholder proposals and director nominations is October 10, 2022.","Proposals must be submitted in writing to Secretary David Jorden at the company's address."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-22-023298","json":"https://secwatch.observer/filing/0001437749-22-023298.json","markdown":"https://secwatch.observer/filing/0001437749-22-023298.md","text":"https://secwatch.observer/filing/0001437749-22-023298.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1091596/000143774922023298/0001437749-22-023298-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1091596/000143774922023298/aurx20220926_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T06:16:06.251297+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}